abstract |
Features of the present invention include recombinant mammalian E-selectin peptides, nucleic acids encoding the peptides, vectors and cells having these nucleic acids, and methods for producing the peptides. In addition, features of the invention include methods of treating diseases and conditions associated with inflammation using recombinant mammalian E-selectin peptides that induce mucosal tolerance to E-selectin. |